Atlas Trials

Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.

Clinical trial NCT01290042 · COMPLETED

Trial details

NCT number
NCT01290042
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Ulcerative ColitisCrohn's Disease
Start date
2011-02-01
Primary completion
2014-04-01
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.